Company
Aphria Inc.
Headquarters: Leamington, ON, Canada
Founded: 2014
Employees: 1,200
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Aphria Inc. has the following listings and related stock indices.
Stock: TSX: APHA wb_incandescent
Stock: NASDAQ: APHA wb_incandescent
Product & Services
Cannabis
Key People
Founder(s): Cole Cacciavillani John Cervini
Irwin D Simon (Chief Executive Officer)
Financials
Revenue: 36,920,000 Canadian dollar (2018)